The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Mitsushige Sugimoto

Center for Clinical Research

Hamamatsu University School of Medicine

1-20-1 Handayama

Higashi-ku

Japan

[email]@hama-med.ac.jp

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Center for Clinical Research, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Japan. 2004 - 2010

References

  1. Influence of interleukin polymorphisms on development of gastric cancer and peptic ulcer. Sugimoto, M., Yamaoka, Y., Furuta, T. World J. Gastroenterol. (2010) [Pubmed]
  2. Role of angiotensinogen gene polymorphism on Helicobacter pylori infection-related gastric cancer risk in Japanese. Sugimoto, M., Furuta, T., Shirai, N., Kodaira, C., Nishino, M., Ikuma, M., Sugimura, H., Hishida, A. Carcinogenesis (2007) [Pubmed]
  3. Evidence that the degree and duration of acid suppression are related to Helicobacter pylori eradication by triple therapy. Sugimoto, M., Furuta, T., Shirai, N., Kodaira, C., Nishino, M., Ikuma, M., Ishizaki, T., Hishida, A. Helicobacter (2007) [Pubmed]
  4. Effects of interleukin-10 gene polymorphism on the development of gastric cancer and peptic ulcer in Japanese subjects. Sugimoto, M., Furuta, T., Shirai, N., Nakamura, A., Kajimura, M., Sugimura, H., Hishida, A. J. Gastroenterol. Hepatol. (2007) [Pubmed]
  5. Treatment strategy to eradicate Helicobacter pylori infection: impact of pharmacogenomics-based acid inhibition regimen and alternative antibiotics. Sugimoto, M., Furuta, T., Shirai, N., Kodaira, C., Nishino, M., Yamade, M., Ikuma, M., Watanabe, H., Ohashi, K., Hishida, A., Ishizaki, T. Expert. Opin. Pharmacother (2007) [Pubmed]
  6. Different effects of polymorphisms of tumor necrosis factor-alpha and interleukin-1 beta on development of peptic ulcer and gastric cancer. Sugimoto, M., Furuta, T., Shirai, N., Nakamura, A., Xiao, F., Kajimura, M., Sugimura, H., Hishida, A. J. Gastroenterol. Hepatol. (2007) [Pubmed]
  7. Influences of proinflammatory and anti-inflammatory cytokine polymorphisms on eradication rates of clarithromycin-sensitive strains of Helicobacter pylori by triple therapy. Sugimoto, M., Furuta, T., Shirai, N., Ikuma, M., Hishida, A., Ishizaki, T. Clin. Pharmacol. Ther. (2006) [Pubmed]
  8. Influences of chymase and angiotensin I-converting enzyme gene polymorphisms on gastric cancer risks in Japan. Sugimoto, M., Furuta, T., Shirai, N., Ikuma, M., Sugimura, H., Hishida, A. Cancer Epidemiol. Biomarkers Prev. (2006) [Pubmed]
  9. Initial 48-hour acid inhibition by intravenous infusion of omeprazole, famotidine, or both in relation to cytochrome P450 2C19 genotype status. Sugimoto, M., Furuta, T., Shirai, N., Ikuma, M., Hishida, A., Ishizaki, T. Clin. Pharmacol. Ther. (2006) [Pubmed]
  10. Comparison of an increased dosage regimen of rabeprazole versus a concomitant dosage regimen of famotidine with rabeprazole for nocturnal gastric acid inhibition in relation to cytochrome P450 2C19 genotypes. Sugimoto, M., Furuta, T., Shirai, N., Nakamura, A., Kajimura, M., Hishida, A., Ohashi, K., Ishizaki, T. Clin. Pharmacol. Ther. (2005) [Pubmed]
  11. Poor metabolizer genotype status of CYP2C19 is a risk factor for developing gastric cancer in Japanese patients with Helicobacter pylori infection. Sugimoto, M., Furuta, T., Shirai, N., Nakamura, A., Kajimura, M., Sugimura, H., Hishida, A., Ishizaki, T. Aliment. Pharmacol. Ther. (2005) [Pubmed]
  12. Different dosage regimens of rabeprazole for nocturnal gastric acid inhibition in relation to cytochrome P450 2C19 genotype status. Sugimoto, M., Furuta, T., Shirai, N., Kajimura, M., Hishida, A., Sakurai, M., Ohashi, K., Ishizaki, T. Clin. Pharmacol. Ther. (2004) [Pubmed]
 
WikiGenes - Universities